Moderna earnings: Losses narrow as biotech cuts costs
Moderna is working on restoring investors' faith that its Covid-19 vaccine was not a one-hit-wonder. It also has to show it can get its costs under control. On Friday, the company announced fourth-quarter earnings, including ...
Moderna is working on restoring investors' faith that its Covid-19 vaccine was not a one-hit-wonder. It also has to show it can get its costs under control.
On Friday, the company announced fourth-quarter earnings, including ...
